Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with<sup>89</sup>Zr or<sup>211</sup>At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with⁸⁹Zr or²¹¹At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma

Published:2023-10-12 Issue:12 Volume:64 Page:1949-1955
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Watabe Tadashi,Kabayama Kazuya,Naka Sadahiro,Yamamoto Ryuku,Kaneda Kazuko,Serada Satoshi,Ooe Kazuhiro,Toyoshima Atsushi,Wang Yang,Haba Hiromitsu,Kurimoto Kenta,Kobayashi Takanori,Shimosegawa Eku,Tomiyama Noriyuki,Fukase Koichi,Naka Tetsuji

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review;Elbanna;Insights Imaging.,2020

3. Initial Evaluation of [¹⁸F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions

4. Role of glypican-1 in regulating multiple cellular signaling pathways;Pan;Am J Physiol Cell Physiol.,2021

5. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma;Munekage;Neoplasia.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11

2. Development of the Precision-designed Radiopharmaceuticals Depending on the Targeting Molecules;RADIOISOTOPES;2024-07-15

3. Glypican-1-targeted antibody–drug conjugate inhibits the growth of glypican-1-positive glioblastoma;Neoplasia;2024-04

4. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19